Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset.

International journal of clinical oncology·2013

Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.

Cancer treatment reviews·2008

Diagnostic and therapeutic management of cancer of an unknown primary.

European journal of cancer (Oxford, England : 1990)·2003

Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2001

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.

Cancer·2001

The role of fumarate and itaconate in tumor microenvironment.

Seminars in oncology·2026

Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons.

Seminars in oncology·2026

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Seminars in oncology·2026

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Seminars in oncology·2026

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Seminars in oncology·2026

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Seminars in oncology·2026

Corrigendum to: ARL6IP1 Inhibits Breast Cancer Tumor Progression by Targeting OLFM4 to Regulate Glycolysis.

Combinatorial chemistry & high throughput screening·2026

Claudin 18 is not a biomarker for breast mucinous tumor.

Journal of the Chinese Medical Association : JCMA·2026

Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.

Journal of the National Cancer Institute·2026

Neurodevelopmental Disorder Associated with Aluminum-Adsorbed Vaccines: Reanalysis of Data from a Danish Nationwide Cohort Study.

Integrative medicine (Encinitas, Calif.)·2026

Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study.

EClinicalMedicine·2026

Systematic review of PET imaging features and clinical applications in pulmonary NUT carcinoma.

Frontiers in radiology·2026

Related Experiment Videos

Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site

Related Concept Videos

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset.

Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.

Diagnostic and therapeutic management of cancer of an unknown primary.

Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer.

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.

The role of fumarate and itaconate in tumor microenvironment.

Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons.

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Corrigendum to: ARL6IP1 Inhibits Breast Cancer Tumor Progression by Targeting OLFM4 to Regulate Glycolysis.

Claudin 18 is not a biomarker for breast mucinous tumor.

Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.

Neurodevelopmental Disorder Associated with Aluminum-Adsorbed Vaccines: Reanalysis of Data from a Danish Nationwide Cohort Study.

Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study.

Systematic review of PET imaging features and clinical applications in pulmonary NUT carcinoma.

Related Experiment Videos

Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site

Related Concept Videos

Related Articles